Advisors Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,043
Closed -$309K 1560
2020
Q3
$309K Sell
3,043
-33
-1% -$3.37K 0.01% 1055
2020
Q2
$299K Sell
3,076
-62
-2% -$5.77K 0.01% 1062
2020
Q1
$261K Sell
3,138
-207
-6% -$20.2K 0.01% 1047
2019
Q4
$372K Sell
3,345
-1,080
-24% -$111K 0.01% 1068
2019
Q3
$439K Sell
4,425
-115
-3% -$11.4K 0.01% 1010
2019
Q2
$450K Sell
4,540
-704
-13% -$67.2K 0.01% 1033
2019
Q1
$578K Buy
5,244
+1,746
+50% +$182K 0.01% 1036
2018
Q4
$322K Buy
3,498
+797
+30% +$80.6K 0.01% 1096
2018
Q3
$298K Sell
2,701
-303
-10% -$31.5K ﹤0.01% 1167
2018
Q2
$280K Buy
3,004
+364
+14% +$31.3K ﹤0.01% 1171
2018
Q1
$222K Buy
2,640
+1,311
+99% +$116K ﹤0.01% 1221
2017
Q4
$121K Buy
1,329
+516
+63% +$42.9K ﹤0.01% 1322
2017
Q3
$62K Buy
813
+511
+169% +$38.6K ﹤0.01% 1388
2017
Q2
$23K Buy
+302
New +$20.9K ﹤0.01% 1488

Other funds holding PRAH

Advisors Asset Management's PRAH Position: Q4 2020 in Review

Advisors Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 3,043 shares — an estimated $309K sold.

Advisors Asset Management first reported a position in PRAH in Q2 2017 and held it in 14 quarters. The position peaked at $578K in Q1 2019. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

  • Advisors Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Advisors Asset Management sold 3,043 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $309K.
  • Advisors Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 14 quarters.
  • Advisors Asset Management's PRA Health Sciences, Inc. position peaked at $578K in Q1 2019.
  • 289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Advisors Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.